scispace - formally typeset
P

Paul Devroey

Researcher at Vrije Universiteit Brussel

Publications -  527
Citations -  42194

Paul Devroey is an academic researcher from Vrije Universiteit Brussel. The author has contributed to research in topics: Intracytoplasmic sperm injection & Pregnancy. The author has an hindex of 104, co-authored 526 publications receiving 39887 citations. Previous affiliations of Paul Devroey include Free University of Brussels & Siemens.

Papers
More filters
Journal ArticleDOI

Use of pentoxifylline in assisted reproductive technology

TL;DR: Data from controlled studies indicate that an indiscriminate use of 3.6 mM pentoxifylline, alone or in combination with 3.0 mM 2-deoxyadenosine, is not beneficial in enhancing fertilization rates in zero and poor in-vitro fertilizers or in the presence of antisperm antibodies.
Journal ArticleDOI

Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response

TL;DR: Clinicians treating IVF patients with corifollitropin alfa should alter their treatment paradigm as a lower or higher dose than recommended according to body weight does not affect the ovarian response, which depends mainly on the ovarian reserve.
Journal ArticleDOI

Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles

TL;DR: Endometrial gene-expression findings support the clinical reports of a non-significant difference in live birth rates between the GnRH agonist trigger and the hCG trigger, when the Gn RH agonisttrigger is followed by a bolus of 1500 IU hCG at 35 h post trigger in addition to the standard luteal phase support.
Journal ArticleDOI

Tubal surgery in the era of assisted reproductive technology: clinical options

TL;DR: It is thought that IVF and tubal surgery must be considered to be complementary rather than competitive procedures.
Journal ArticleDOI

Cumulative delivery rates after ICSI in women aged >37 years.

TL;DR: This life-table analysis provides a means by which to counsel couples about their chances of achieving a delivery by ICSI at an age >37 years, and women aged >43 years do not have a realistic chance of achieve a delivery with their own oocytes.